Dyslipidemia involvement in the development of polycystic ovary syndrome
Polycystic ovary syndrome (PCOS) is widely accepted as the most common endocrine abnormality in women of childbearing age and may be accompanied by dyslipidemia, hyperandrogenism, hyperinsulinemia, oxidative stress and infertility. Dyslipidemia is now known to play an important role in the developme...
Saved in:
Main Authors: | Qi Liu (Author), Yuan-jie Xie (Author), Li-hua Qu (Author), Meng-xia Zhang (Author), Zhong-cheng Mo (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2019-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Hypoadiponectinemia: A useful marker of dyslipidemia in women with polycystic ovary syndrome
by: Chih-Yuan Chang, et al.
Published: (2012) -
Inflammatory markers in lean Polycystic Ovary Syndrome subjects are not associated with the spectrum of dyslipidemia
by: Elisia Atnil, et al.
Published: (2022) -
Correlation and predictive value of systemic immune-inflammation index for dyslipidemia in patients with polycystic ovary syndrome
by: Xinyue Zhou, et al.
Published: (2024) -
Polycystic Ovary Syndrome
Published: (2012) -
Is interleukin-18 associated with polycystic ovary syndrome?
by: Li Rong, et al.
Published: (2011)